Aitken et al [289,290] at The Ohio State University (Columbus, Ohio, USA) first reported radioimmunoguided surgery using 131I-labeled anti-CEA polyclonal antibody to detect colorectal cancer. This evidence concerns the gene CEACAM5 and colorectal cancer.